All Articles

In this installment of Navigation Refresh, we break down the 2026 updates to CMS Principal Illness Navigation codes. Learn what’s new, what’s stayed the same, and how these changes impact your role.
Read More

How do we prepare the next generation of patient navigators? Discover how one institution developed a groundbreaking bachelor’s program to equip students with the skills and compassion necessary to meet the growing demand for this essential profession.
Read More

Treatment of Patients With Node-Positive, HR-Positive/HER2-Negative Early Breast Cancer at High Risk of Recurrence: monarchE 7-Year Outcomes
In his expert commentary, Seth Wander, MD, PhD, provides a comprehensive review of the latest data on the cyclin-dependent kinase (CDK)4/6 inhibitor abemaciclib for treating of high-risk, node-positive, hormone receptor–positive/HER2-negative early breast cancer.
Read More

Colorectal Cancer Awareness Month is a powerful reminder that meaningful progress in cancer care relies on action, collaboration, and the dedication of navigators who ensure no one is left behind.
Read More

The NCCN’s Health Equity Report Card is transforming cancer care by providing community practices and patient navigators with actionable tools to address disparities, improve access, and deliver equitable outcomes for all patients.
Read More

In this first edition of a new JONS feature, we’re spotlighting 6 groundbreaking advancements transforming colorectal cancer care.
Read More

In this installment of Navigation Refresh, learn how navigation is improving colorectal cancer care through tailored screening strategies, emerging resources, and innovative solutions to enhance outcomes across diverse populations.
Read More

An innovative new project from Northwell Health Cancer Institute and IA Collaborative is poised to address critical gaps in care through the combination of technology and patient navigator skill.
Read More

Quality Improvement Strategies to Optimize Outpatient Step-Up Dosing for Elranatamab in Relapsed/Refractory Multiple Myeloma
In this publication, clinical experts from Massachusetts General Hospital (MGH) examine quality improvement (QI) and quality assurance (QA) strategies that support the safe and effective outpatient administration of bispecific antibodies such as elranatamab in patients with relapsed/refractory multiple myeloma.
Read More

Oncology navigation is ever-evolving, and so is the way we tell its story. The start of the new year marks our renewed commitment to celebrating its impact and delivering insights that empower what comes next.
Read More

Page 2 of 283

Journal of Oncology Navigation & Survivorship
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country